Repigmentation through Melanocyte Regeneration in Vitiligo.

[1]  M. Cario-André,et al.  Clinical repigmentation patterns in paediatric vitiligo , 2016, The British journal of dermatology.

[2]  G. Sisti,et al.  Effectiveness and safety of topical tacrolimus monotherapy for repigmentation in vitiligo: a comprehensive literature review* , 2016, Anais brasileiros de dermatologia.

[3]  Qiang Li,et al.  Effect of topical calcineurin inhibitors as monotherapy or combined with phototherapy for vitiligo treatment: a meta‐analysis , 2016, Dermatologic therapy.

[4]  S. Chang,et al.  FK506 regulates pigmentation by maturing the melanosome and facilitating their transfer to keratinocytes , 2016, Pigment cell & melanoma research.

[5]  A. Christiano,et al.  Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA). , 2016, Journal of the American Academy of Dermatology.

[6]  J. Harris,et al.  Interfering with the IFN-γ/CXCL10 pathway to develop new targeted treatments for vitiligo. , 2015, Annals of translational medicine.

[7]  R. Ballotti,et al.  Transcriptional Analysis of Vitiligo Skin Reveals the Alteration of WNT Pathway: A Promising Target for Repigmenting Vitiligo Patients. , 2015, The Journal of investigative dermatology.

[8]  A. Christiano,et al.  Pharmacologic inhibition of JAK-STAT signaling promotes hair growth , 2015, Science Advances.

[9]  S. Chang,et al.  Development of Vitiligo during Treatment with Adalimumab: A Plausible or Paradoxical Response? , 2015, Annals of dermatology.

[10]  B. King,et al.  Tofacitinib Citrate for the Treatment of Vitiligo: A Pathogenesis-Directed Therapy. , 2015, JAMA dermatology.

[11]  D. Roop,et al.  Narrow Band Ultraviolet B Treatment for Human Vitiligo Is Associated with Proliferation, Migration, and Differentiation of Melanocyte Precursors. , 2015, The Journal of investigative dermatology.

[12]  Eun-So Lee,et al.  Changes of Epidermal Thickness in Vitiligo , 2015, The American Journal of dermatopathology.

[13]  M. Picardo,et al.  Vitiligo: characterization of melanocytes in repigmented skin after punch grafting , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

[14]  J. Leonardi-Bee,et al.  Interventions for vitiligo. , 2015, The Cochrane database of systematic reviews.

[15]  C. Hunter,et al.  Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo , 2014, The Journal of investigative dermatology.

[16]  H. Nakauchi,et al.  A melanocyte–melanoma precursor niche in sweat glands of volar skin , 2014, Pigment cell & melanoma research.

[17]  P. Sun,et al.  Pygo2 regulates β-catenin–induced activation of hair follicle stem/progenitor cells and skin hyperplasia , 2014, Proceedings of the National Academy of Sciences.

[18]  E. Morrisey,et al.  Distinct functions for Wnt/β-catenin in hair follicle stem cell proliferation and survival and interfollicular epidermal homeostasis. , 2013, Cell stem cell.

[19]  S. Nakata,et al.  Wnt/β-catenin and kit signaling sequentially regulate melanocyte stem cell differentiation in UVB-induced epidermal pigmentation. , 2013, The Journal of investigative dermatology.

[20]  M. García-Carrasco,et al.  Treatment of vitiligo with a chimeric monoclonal antibody to CD20: a pilot study , 2013, Clinical and experimental immunology.

[21]  A. Jimeno,et al.  Epithelial stem cell mutations that promote squamous cell carcinoma metastasis. , 2013, The Journal of clinical investigation.

[22]  M. Leandro,et al.  Deterioration of vitiligo and new onset of halo naevi observed in two patients receiving adalimumab , 2013, Dermatologic therapy.

[23]  Piul S. Rabbani,et al.  Direct migration of follicular melanocyte stem cells to the epidermis after wounding or UVB irradiation is dependent on Mc1r signaling , 2013, Nature Medicine.

[24]  R. Spritz.  Modern vitiligo genetics sheds new light on an ancient disease , 2013, The Journal of dermatology.

[25]  A. Lin,et al.  Efficacy of topical calcineurin inhibitors in vitiligo , 2013, International journal of dermatology.

[26]  M. Ludovici,et al.  Vitiligo: A Possible Model of Degenerative Diseases , 2013, PloS one.

[27]  M. Nishimura,et al.  Mutant HSP70 Reverses Autoimmune Depigmentation in Vitiligo , 2013, Science Translational Medicine.

[28]  W. Hsu,et al.  Epidermal Wnt controls hair follicle induction by orchestrating dynamic signaling crosstalk between the epidermis and dermis , 2012, The Journal of investigative dermatology.

[29]  Kimberly Johnson,et al.  Extrafollicular Dermal Melanocyte Stem Cells and Melanoma , 2012, Stem cells international.

[30]  K. Alghamdi,et al.  Treatment of generalized vitiligo with anti-TNF-α Agents. , 2012, Journal of drugs in dermatology : JDD.

[31]  D. Torchia,et al.  Tumor necrosis factor-α in vitiligo: direct correlation between tissue levels and clinical parameters , 2011, Cutaneous and ocular toxicology.

[32]  T. Hirobe.  How are proliferation and differentiation of melanocytes regulated? , 2011, Pigment cell & melanoma research.

[33]  Yiwei Zhao,et al.  Statins downregulate K6a promoter activity: a possible therapeutic avenue for pachyonychia congenita. , 2011, The Journal of investigative dermatology.

[34]  A. Batalla,et al.  Vitiligo during Treatment of Crohn's Disease with Adalimumab: Adverse Effect or Co-Occurrence? , 2011, Case Reports in Dermatology.

[35]  M. Ziman,et al.  PAX3 Expression in Normal Skin Melanocytes and Melanocytic Lesions (Naevi and Melanomas) , 2010, PloS one.

[36]  Yun-Seok Yang,et al.  Clinical study of repigmentation patterns with either narrow‐band ultraviolet B (NBUVB) or 308 nm excimer laser treatment in Korean vitiligo patients , 2010, International journal of dermatology.

[37]  R. Falabella.  VITILIGO AND THE MELANOCYTE RESERVOIR , 2009, Indian journal of dermatology.

[38]  M. Osawa.  Melanocyte stem cells , 2009 .

[39]  G. Costin,et al.  New insights on therapy with vitamin D analogs targeting the intracellular pathways that control repigmentation in human vitiligo , 2009, Medicinal research reviews.

[40]  L. Davids,et al.  A rare repigmentation pattern in a vitiligo patient: a clue to an epidermal stem‐cell reservoir of melanocytes? , 2009, Clinical and experimental dermatology.

[41]  A. Hachiya,et al.  The Essential Role of p53 in Hyperpigmentation of the Skin via Regulation of Paracrine Melanogenic Cytokine Receptor Signaling* , 2009, Journal of Biological Chemistry.

[42]  R. Paus,et al.  Evidence that the bulge region is a site of relative immune privilege in human hair follicles , 2008, The British journal of dermatology.

[43]  G. Costin,et al.  Cellular and molecular mechanisms involved in the action of vitamin D analogs targeting vitiligo depigmentation. , 2008, Current drug targets.

[44]  D. I. Smith,et al.  Vitiligo after the resolution of psoriatic plaques during treatment with adalimumab. , 2008, Journal of the American Academy of Dermatology.

[45]  D. Parsad,et al.  Understanding the Mechanisms of Repigmentation in Vitiligo , 2007 .

[46]  S. Stevenson,et al.  Effect of estrogens on skin aging and the potential role of SERMs , 2007, Clinical interventions in aging.

[47]  S. Gregoriou,et al.  Etanercept in the Treatment of Vitiligo , 2007, Dermatology.

[48]  V. Hearing,et al.  Human skin pigmentation: melanocytes modulate skin color in response to stress , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[49]  H. Y. Kang,et al.  FK506 increases pigmentation and migration of human melanocytes , 2006, The British journal of dermatology.

[50]  B. Kumar,et al.  Psoralen–ultraviolet A vs. narrow‐band ultraviolet B phototherapy for the treatment of vitiligo , 2006, Journal of the European Academy of Dermatology and Venereology : JEADV.

[51]  S. Dogra,et al.  Repigmentation in vitiligo universalis: role of melanocyte density, disease duration, and melanocytic reservoir. , 2005, Dermatology online journal.

[52]  Sung Bin Cho,et al.  Various Patterns of Repigmentation after Narrowband UVB Monotherapy in Patients with Vitiligo , 2005, The Journal of dermatology.

[53]  C. Lan,et al.  FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes: possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo , 2005, The British journal of dermatology.

[54]  D. Fisher,et al.  Mechanisms of Hair Graying: Incomplete Melanocyte Stem Cell Maintenance in the Niche , 2005, Science.

[55]  S. Nishikawa,et al.  Dominant role of the niche in melanocyte stem-cell fate determination , 2002, Nature.

[56]  S. Nishikawa,et al.  Review: melanocyte migration and survival controlled by SCF/c-kit expression. , 2001, The journal of investigative dermatology. Symposium proceedings.

[57]  Glenville Jones.  Vitamin D analogs. , 2001, Endocrinology and metabolism clinics of North America.

[58]  Y. Kawaguchi,et al.  Kit(+) melanocytes seem to contribute to melanocyte proliferation after UV exposure as precursor cells. , 2001, The Journal of investigative dermatology.

[59]  D. Tobin,et al.  Melanocytes are not absent in lesional skin of long duration vitiligo. , 2000, The Journal of pathology.

[60]  K. Will,et al.  P53-Dependent UVB Responsiveness of Human Keratinocytes Can Be Altered by Cultivation on Cell Cycle-arrested Dermal Fibroblasts , 2000, Photochemistry and photobiology.

[61]  P M Bossuyt,et al.  Nonsurgical repigmentation therapies in vitiligo. Meta-analysis of the literature. , 1998, Archives of dermatology.

[62]  S. Nishikawa,et al.  Transgene expression of steel factor in the basal layer of epidermis promotes survival, proliferation, differentiation and migration of melanocyte precursors. , 1998, Development.

[63]  C. Scaletta,et al.  Sunlight and carcinogenesis: Expression of p53 and pyrimidine dimers in human skin following UVA I, UVA I + II and solar simulating radiations , 1998, International journal of cancer.

[64]  J. A. Burch,et al.  KIT expression reveals a population of precursor melanocytes in human skin. , 1996, The Journal of investigative dermatology.

[65]  E. Carrascal,et al.  MELANOCYTE RESERVOIR IN VITILIGO , 1994, International journal of dermatology.

[66]  S. Im,et al.  The change of melanocyte cytotoxicity after systemic steroid treatment in vitiligo patients. , 1993, Journal of dermatological science.

[67]  J Cui,et al.  Role of hair follicles in the repigmentation of vitiligo. , 1991, The Journal of investigative dermatology.

[68]  J. Pasricha,et al.  Demonstration of tyrosinase in the vitiligo skin of human beings by a sensitive fluorometric method as well as by 14C(U)-L-tyrosine incorporation into melanin. , 1982, The Journal of investigative dermatology.

[69]  R. Staricco.  AMELANOTIC MELANOCYTES IN THE OUTER SHEATH OF THE HUMAN HAIR FOLLICLE AND THEIR ROLE IN THE REPIGMENTATION OF REGENERATED EPIDERMIS * , 1963, Annals of the New York Academy of Sciences.

[70]  R. Staricco,et al.  Activation of the amelanotic melanocytes in the outer root sheath of the hair follicle following ultra violet rays exposure. , 1962, The Journal of investigative dermatology.

[71]  M. Lebwohl,et al.  Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial. , 2015, JAMA dermatology.

[72]  D. Parsad.  Natural History and Prognosis , 2010 .

[73]  K. Wolff,et al.  Fitzpatrick's Dermatology in General Medicine. 7th Edition , 2008 .

[74]  S. Dogra,et al.  Clinical study of repigmentation patterns with different treatment modalities and their correlation with speed and stability of repigmentation in 352 vitiliginous patches. , 2004, Journal of the American Academy of Dermatology.

[75]  T. Horikawa,et al.  DOPA-negative melanocytes in the outer root sheath of human hair follicles express premelanosomal antigens but not a melanosomal antigen or the melanosome-associated glycoproteins tyrosinase, TRP-1, and TRP-2. , 1996, The Journal of investigative dermatology.

[76]  D. Tobin,et al.  Isolation and long-term culture of human hair-follicle melanocytes. , 1995, The Journal of investigative dermatology.

[77]  J. Ortonne,et al.  PUVA-induced repigmentation of vitiligo: scanning electron microscopy of hair follicles. , 1980, The Journal of investigative dermatology.

[78]  Thomas B. Fitzpatrick,et al.  Dermatology in general medicine , 1971 .

[79]  G. Moschonis,et al.  Lipids in Health and Disease Distribution of Serum Lipids and Lipoproteins in Patients with Beta Thalassaemia Major; an Epidemiological Study in Young Adults from Greece , 2022 .